Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1). . ebph [Internet]. 2022 May 10 [cited 2026 Jul. 28];12(2). Available from: https://test-ojs-unimi-it.archicoop.it/index.php/ebph/article/view/17832